![](https://investorshub.advfn.com/uicon/8777.png?cb=1703671008)
Monday, March 11, 2019 2:19:30 PM
Why don't we know what the real risks are for an individual? Probably because once they get approval the industry doesn't care or follow up, there's no money in it.
Growth in total knee replacement utilization has been disproportionately high among younger individuals (forty-five to sixty-four years old)12-14. As a result, the average age at which patients receive total knee replacement has decreased over time4. The rapid growth in total knee replacement utilization among younger adults, coupled with increased life expectancy, implies that many more individuals are living with total knee replacement longer than ever before.
Despite a high success rate and relatively low risks of failure and/or complications, as more adults in the U.S. undergo total knee replacement, the population at risk for such complications increases. While the annual utilization of total knee replacement over time has been described12,14,15, estimates of the number of persons in the U.S. living with knee implants have not been reported, to our knowledge. Such estimates would be useful in planning health services specific to the population living with total knee replacement, such as anticipation of revision total knee replacement and management of periprosthetic fractures and infections. We aimed to quantify the burden of total knee replacement in the U.S. by estimating the number of adults currently alive with a primary or revision total knee replacement.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748969/
The incidence of joint replacement procedures is high, with over 1 million total hip and total knee replacement procedures performed each year in the United States1. With the aging of the “baby boomers,” higher rates of diagnosis and treatment of advanced arthritis, and growing demand for improved mobility and quality of life, the annual procedure volumes are projected to increase considerably in the future, making joint replacements the most common elective surgical procedures in the coming decades2,3. Such a large increase in demand is unprecedented and must be addressed with effective planning of health-care services for these individuals, not only during the perioperative period but throughout the lifelong continued care of this population.
To date, studies involving the descriptive epidemiology of total hip and total knee replacement have focused almost exclusively on annual procedure volumes (i.e., incidence)2-9. Although incidence data are informative, they offer an incomplete assessment of the impact of total hip and total knee replacement on the population and the health-care system. The prevalence of individuals who are currently living with an artificial hip or knee joint in the United States is currently unknown. Indeed, the increasing use of joint replacement in younger individuals, coupled with improvements in life expectancy, has created a large pool of individuals with hip and knee replacements in the United States2,10. These individuals not only have specialized needs, but in some cases, will outlive their implants and require expensive revision surgeries with substantial implications related to cost and resource use. Therefore, estimates of prevalence are vital to agencies charged with planning for the provision of health-care services for these individuals. We know of only one study to date that has provided prevalence estimates of total knee replacement, but the methodology used to estimate prevalence was based on a computer-simulation model of the natural history of osteoarthritis and did not take into account the substantial increase in procedure volumes in recent years. Therefore, we sought to estimate the current prevalence and historical trends in the prevalence of total hip and total knee replacement in the United States using multiple data sources and accounting for the secular increase in procedure volumes in recent years.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551172/
Recent AVXL News
- Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference • GlobeNewswire Inc. • 06/20/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:30:10 AM
- Anavex Life Sciences Announces Expansion of Leadership Team • GlobeNewswire Inc. • 05/22/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 10:01:00 AM
- Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 05/10/2024 09:45:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:35:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:00:30 PM
- Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders • PR Newswire (US) • 05/07/2024 09:45:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 10:03:33 AM
- Anavex Life Sciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before May 13, 2024 to Discuss Your Rights - AVXL • PR Newswire (US) • 05/03/2024 09:45:00 AM
- Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024 • GlobeNewswire Inc. • 05/02/2024 11:30:00 AM
- May 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXL • PR Newswire (US) • 04/26/2024 09:45:00 AM
- Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL) • PR Newswire (US) • 04/19/2024 09:45:00 AM
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXL • PR Newswire (US) • 04/16/2024 09:45:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/12/2024 09:45:00 AM
- Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference • GlobeNewswire Inc. • 04/11/2024 11:30:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/09/2024 09:45:00 AM
- Anavex Life Sciences Corporation Class Action: The Gross Law Firm Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXL • PR Newswire (US) • 04/05/2024 09:45:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 04/02/2024 09:45:00 AM
- Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm • PR Newswire (US) • 03/29/2024 09:45:00 AM
- Investors who lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 03/26/2024 09:45:00 AM
- Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 03/25/2024 11:30:00 AM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM